What top creators are saying about Insmed Incorporated(INSM)
Biopharmaceutical company
2 AI-extracted insights from 2 sources — podcasts, YouTube channels, and X/Twitter accounts.
Creator sentiment — last 30 days
Based on 1 scored insight about Insmed Incorporated.
Top creators covering Insmed Incorporated (INSM)
The 2 sources with the most insights about Insmed Incorporated on Kazuha.
Latest insights about Insmed Incorporated (INSM)
AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.
Tuesday, July 14, 2026
Strong drug trajectory for Brensocatib, but high valuation suggests much of the upside is already priced in.
Wednesday, December 31, 2025
Mentioned as a liked small-cap biotech name that could be an M&A target. Noted to have pulled back from $212 to $175.
Tuesday, July 14, 2026
Strong drug trajectory for Brensocatib, but high valuation suggests much of the upside is already priced in.
Wednesday, December 31, 2025
Mentioned as a liked small-cap biotech name that could be an M&A target. Noted to have pulled back from $212 to $175.
Discussed alongside Insmed Incorporated (INSM)
Other assets that creators frequently mention in the same content as Insmed Incorporated.
Frequently asked
Which podcasters and creators cover Insmed Incorporated (INSM) the most?
The most active sources covering Insmed Incorporated (INSM) on Kazuha are @realmartinshkreli, RiskReversal Media. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.
How many insights about Insmed Incorporated (INSM) are on Kazuha?
Kazuha has indexed 2 AI-extracted insights about Insmed Incorporated (INSM) from 2 different sources. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.
What other assets do creators discuss alongside Insmed Incorporated (INSM)?
Creators covering Insmed Incorporated (INSM) most frequently also discuss BMY, NEM, TXG, C, JPM. See the "Discussed alongside" section above for full asset pages.